Please log into your account for a discounted member rate!
Total Credits: 1 including 1 AMA PRA Category 1 Credit(s)™, 1 AOA Category 1-A Credit(s)
This program will expire and must be completed by 10/21/27.
** Please note this program was a part of the VOC 2024. You will not want to choose this program if you completed this individual program as part of the VOC 2024. **
This presentation will review POTS/Dysautonomia, which has become more common since COVID-19 arrived on the scene. The signs and symptoms of POTS/Dysautonomia will be discussed, and the latest treatment options will be reviewed.
Objectives:
• Consider the pathophysiology of dysautonomia and POTS
• Consider this pathophysiology being mediated by direct biotoxin action / infection and by mast cell activation
• Consider the full presentation being that of “The Pentad” and progression along “The Spiky-Leaky Pathway”
• Consider therapies to manage Dysautonomia, POTS, and MCAS
Accreditation Statements:
This program is co-sponsored by the Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) and the Osteopathic Physicians and Surgeons of Oregon (OPSO). Both osteopathic associations are accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians.
The program has been designated for a maximum of one (1) AOA Category 1-A Credit(s) by the co-sponsors who have authorized the Missouri Association of Osteopathic Physicians and Surgeons to report CME and specialty credits to the AOA commensurate with the extent of the physician's participation in this activity.
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this conference for a maximum of one (1) AMA PRA Category 1 Credit(s)ä. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Disclosure:
The Virtual CME Committee consisting of representatives from the Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) and the Osteopathic Physicians and Surgeons of Oregon (OPSO), has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of these presentations.
Osteopathic Grievance Policy:
All grievances should be in writing and should specify the nature of the grievance. Initially, all grievances should be directed to the MAOPS Executive Director, who will then forward said grievance to the Virtual CME Committee. All grievances will receive an initial response in writing within 30 days of receipt. If the participant does not receive a satisfactory response, they can then submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
Dr. Maxwell Handout/Slides (9.58 MB) | 107 Pages | Available after Purchase |
Dr. Maxwell is a Pediatric Cardiologist and Pediatrician at Heart of the Valley Pediatric Cardiology in Pleasanton, California. He received his medical degree from Johns Hopkins Medical School and completed a Residency in Pediatrics at The University of California at San Francisco. He then completed clinical and research fellowships in Pediatric Cardiology at Lucile Salter Packard and Stanford Hospitals in Palo Alto, California, and Children's Hospital of Philadelphia in Pennsylvania. Dr. Maxwell is board certified in Pediatrics and Pediatric Cardiology by the American Board of Pediatrics. He is also a fellow of the American College of Cardiology.
Dr. Maxwell's research interests include the study of endothelial control of vasomotor tone, nitric oxide, sports cardiology, dysautonomia, hypermobility syndromes, & mast cell activation syndrome and their relationships to environmental toxins. For his research, Dr. Maxwell received an American Heart Association Bugher Award for Research in Molecular Biology and was an American College of Cardiology Young Investigator Award finalist. He has published many articles and book chapters on these subjects. For his clinical work, Dr. Maxwell has been voted by his peers as a Top Doctor in Northern California annually since 2017.
Dr. Maxwell discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing healthcare goods or services consumed by or used on patients relative to the content of this presentation.
5 |
|
4 |
|
3 |
|
2 |
|
1 |
|